Zolmitriptan Tablet, Orally Disintegrating
FDA Label NDC 65841-768

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Zolmitriptan (NDC 65841-768). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-767-69 in blister pack of 6 Tablets

Zolmitriptan Orally Disintegrating Tablets, 2.5 mg

Rx only

6 Tablets

Zolmitriptan Od Tablets, 2.5 mg (31419037 52ae 41bb A03e 8965205ab347 01)

Zolmitriptan Od Tablets, 2.5 mg (31419037 52ae 41bb A03e 8965205ab347 01)

NDC 65841-768-87 in blister pack of 3 Tablets

Zolmitriptan Orally Disintegrating Tablets, 5 mg

Rx only

3 Tablets

Zolmitritan Od Tablets, 5 mg (31419037 52ae 41bb A03e 8965205ab347 02)

Zolmitritan Od Tablets, 5 mg (31419037 52ae 41bb A03e 8965205ab347 02)

* Please review the disclaimer below.